In Drosophila, a coordinate interplay between the Rel transcription factor Dorsal and the basic Helix-Loop-Helix transcription factor Twist initiates mesoderm formation by activating the zygotic expression of mesoderm-determining genes. Here, we show that TBPassociated-factors (TAF II s) within the basal transcription factor TFIID mediate transcriptional activation by Dorsal and Twist. Dorsal interacts with TAF II 110 and TAF II 60, while Twist contacts TAF II 110. The TAF II :activator interactions mediate simple and synergistic transactivation by Dorsal and Twist in vitro. Mutations in TAF II 60 or TAF II 110 alleviate the transcription of Dorsal and Twist target genes. Gene dosage assays imply that an interplay of Dorsal and Twist with TAF II 110 is critically required for the activation of mesoderm-determining gene expression in the Drosophila embryo. The results provide evidence that TAF II -subunits within the TFIID complex play an important role during the molecular events leading to initiation of mesoderm formation in Drosophila. q
Introduction
Concentration gradients of signaling molecules or transcription factors have been linked to the initiation of cell fate speci®cation in metazoans (Sander, 1975; Melton, 1991; Greenwald and Rubin, 1992; Cohen, 1996; De Robertis et al., 1997) . These molecules function as morphogens by determining speci®c sequences of various cell types within tissues in a concentration-dependent manner (Driever and Nu Èsslein-Volhard, 1988; St. Johnston and Nu Èsslein-Volhard, 1992; Neumann and Cohen, 1997) . In Drosophila, morphogen gradients specify the primary body axes of the embryo and initiate the formation of body structures and tissues along these axes (St. Johnston and Nu Èsslein-Volhard, 1992; Rush and Levine, 1996) . Dorso-ventral pattern formation in the Drosophila embryo is initiated by the Dorsal morphogen concentration gradient (Roth et al., 1989; Rushlow et al., 1989; Steward, 1989) . Dorsal is a member of the Rel transcription factor family, whose activity is regulated at the level of nuclear translocation (Steward, 1987; Nolan and Baltimore, 1992) . The Dorsal gradient in precellular embryos is established by an elaborate maternal signal transduction pathway, which is highly related to the mammalian interleukin-1 pathway (Wasserman and Steward, 1993; Verma et al., 1995; Drier and Steward, 1997) . Binding of the spa Ètzle ligand to the toll receptor in ventral regions of the embryo triggers a signaling pathway that ultimately releases Dorsal from a cytoplasmic inhibitor, Cactus, and thereby enables Dorsal to enter nuclei (Geisler et al., 1992; Kidd, 1992; Morisato and Anderson, 1995; Belvin and Anderson, 1996) . The asymmetric activity of the maternal signaling pathway creates a nuclear concentration gradient of Dorsal along the dorso-ventral axis of the embryo, with peak levels in ventral nuclei, and progressively lower levels in lateral and dorsal nuclei (Roth et al., 1989; Rushlow et al., 1989; Steward, 1989) . The activity of the Dorsal gradient initiates the differentiation of three embryonic tissues (ventral mesoderm, lateral neuroectoderm and dorsal ectoderm) by regulating the expression of several zygotic genes (Rush and Levine, 1996) .
Dorsal is a sequence-speci®c DNA-binding protein and functions as activator and repressor of transcription in the embryo. In dorsal and dorso-lateral regions Dorsal represses the expression of the dorsal-ectoderm speci®c genes zerknu Èllt and decapentaplegic (Doyle et al., 1989; Kirov et al., 1993; Huang et al., 1995; Dubnicoff et al., 1997) . Moreover, Dorsal functions as a concentration-dependent activator. In lateral cells low Dorsal concentrations activate the expression of neuroectoderm-determining genes (Ip et al., 1992a) , while high Dorsal concentrations activate the expression of mesoderm-determining genes in ventral cells (Jiang et al., 1991; Pan et al., 1991; Thisse et al., 1991; Ip et al., 1992b) . The cell-speci®c response to the different threshold concentrations provided by the Dorsal gradient is thought to be determined by the distinct af®nity of the Dorsal DNA-binding sites present in mesoderm-and neuroectoderm-determining genes (Jiang et al., 1991; Ip et al., 1992b) .
Dorsal initiates the differentiation of the mesoderm by activating the zygotic expression of the determinants twist (twi) and snail (sna) (Jiang et al., 1991; Pan et al., 1991; Thisse et al., 1991; Ip et al., 1992b) . sna encodes a`zinc®nger type' repressor, that inhibits the expression of neuroectoderm-determining genes and thereby establishes the boundary between mesoderm and neuroectoderm (Boulay et al., 1987; Kosman et al., 1991) . Activation of twi expression by Dorsal creates a steep ventro-lateral Twist concentration gradient in early embryos . twi encodes a bHLH transcription factor (Twist) that activates its own expression and sna expression (Jiang et al., 1991; Pan et al., 1991; Thisse et al., 1991; Ip et al., 1992b) . Genetic studies imply that Dorsal cooperates with Twist to establish the precise temporal and spatial expression of mesoderm-determining genes (Jiang et al., 1991; Ip et al., 1992b; Gonza Âles-Crespo and Levine, 1993; . However, little is known about the underlying mechanisms for how Dorsal and Twist activate mesoderm-determining transcription. In particular, it remains currently unclear how Dorsal and Twist communicate with the general transcription machinery to activate transcription.
In eukaryotes, enhancer-bound transcription factors are thought to contact components of the general RNA polymerase II transcription machinery to activate transcription. This machinery is a multi-protein complex comprised of basal transcription factors (TFIIA, B, D, E, F, H, I), RNA polymerase II and associated cofactors (Bjo Èrklund and Kim, 1996; Kaiser and Meisterernst, 1996; Roeder, 1996; Verrijzer and Tjian, 1996; Ptashne and Gann, 1997) . One component targeted by activators is the basal transcription factor TFIID, which is comprised of the TATA-box-binding protein (TBP) and at least eight different TBP-associated factors (TAF II s) (Goodrich and Tjian, 1994) . Different classes of activation domains (i.e. glutamine-, prolinerich) interact with distinct TAF II s and these interactions mediate transcriptional activation in vitro (Verrijzer and Tjian, 1996; Sauer and Tjian, 1997) . Genetic analysis in yeast and Drosophila imply, that certain TAF II s within the TFIID complex are involved in the process of transcriptional activation in vivo (Sauer et al., 1996; Walker et al., 1997; Zhuo et al., 1998) .
In this study, we have investigated the molecular mechanisms underlying transcriptional activation by Dorsal and Twist. In particular, we have addressed the question, which role, if any, TAF II s play for transcriptional activation by Dorsal and Twist in vitro and Drosophila. We show by using a combination of in vitro protein:protein binding assays and cell-free transcription reactions that TAF II -subunits within the TFIID complex, TAF II 110 and TAF II 60,  mediate transcriptional activation by Dorsal and Twist in  vitro . Gene dosage assays demonstrate that mutations in these TAF II -subunits alleviate Dorsal-and Twist-dependent activation of mesoderm-determining gene expression in the Drosophila embryo. We propose that TAF II -subunits of the basal transcription factor TFIID play an important role for the regulatory processes leading to the initiation of mesoderm differentiation in Drosophila.
Results
2.1. twi and sna transcription is sensitive to a reduction of the TAF II 250 gene dosage TAF II 250 is the central subunit within the TFIID complex and essential for the structure and function of the TFIID complex (Verrijzer and Tjian, 1996) . Mutations in TAF II 250 disrupt the TFIID complex and abolish TFIIDdependent transcriptional activation in yeast and mammalian tissue culture cells (Moqtaderi et al., 1996; Walker et al., 1996; Wang et al., 1997) . Therefore, as the initial step to explore a functional role of the basal transcription factor TFIID in Dorsal-and Twist-dependent transcriptional activation, we monitored the expression of Dorsal and Twist target genes in homozygous mutant TAF250 embryos. To sensitize our assay system for changes in transcriptional levels, we used embryos containing reduced activator gene dosages. In wild-type embryos, twi and sna were transcribed in 20 and 18 ventral-most cells, respectively (Fig.  1A,B) . Identical patterns were observed in dorsal (dl)/1 (Fig. 1C,D) and twi/1 embryos (Fig. 1E,F) , indicating that a reduction of the activator gene dosage apparently did not affect twi and sna expression. By contrast, in dlor twi-sensitized, homozygous mutant TAF250 embryos twi and sna expression was restricted to 12±14 and 10±12 ventral-most cells, respectively (Fig. 1G±J ). In addition, the expression domains were disrupted by gaps in the region of the presumptive cephalic furrow and the posterior transverse furrow. By contrast, twi and sna expression was apparently not affected in homozygous mutant TAF250 embryos (Fig. 1K,L) , indicating that twi and sna transcription is alleviated only in embryos containing a reduced concentration of TAF II 250 and either Dorsal or Twist. These ®ndings suggest that a gene dosage sensitive interplay of Dorsal or Twist with TAF II 250 is involved in the activation of sna and twi expression.
Dorsal and Twist interact with TAF II s
The gene dosage assays described above imply that the basal transcription factor TFIID is required for the activa-tion of twi and sna expression by Dorsal and Twist. To provide supporting evidence for this hypothesis, we performed in vitro protein:protein binding assays to identify targets of Dorsal and Twist within the TFIID complex (Sauer et al., 1995) . Both, Dorsal and Twist failed to bind TAF II 250 ( Fig. 2A,B , lane 3) suggesting that TAF II 250 may not serve as a direct target for the activators. Thus, the reduction of Dorsal and Twist target gene expression in (TAF250
2 )-embryos (see Fig. 1 ) most likely re¯ects the involvement of additional TAF II -subunits in transcriptional activation by Dorsal and Twist. We therefore tested whether Dorsal and Twist contact other TAF II -subunits within the TFIID complex. Dorsal interacted with TAF II 110 and TAF II 60 ( Fig. 2A) while Twist bound TAF II 110 only (Fig.  2B ). Neither TAF II 30b ( Fig. 2A,B ) nor several other factors tested (S. Mu Èller, data not shown) interacted with the activators.
To delineate the regions required for the interaction of Dorsal and Twist with TAF II s, we generated truncated activators and tested their capability to interact with TAF II s. The Dorsal activation domain has been allocated to amino acids 402±678 (Shirokawa and Courey, 1997) . TAF II 110 and TAF II 60 interacted with D(402±678) and D(1±531), proteins representing the entire or a part of the Dorsal activation domain (Fig. 2C) . In contrast, both TAF II s failed to interact with D(1±402) lacking the activation domain ( Fig. Fig. 1 . Spatial distribution of twi and sna m-RNA in wildtype and TAF250 mutant embryos. TAF250 mutant embryos were derived from Df(3R) es, carrying a deletion of the TAF250 gene locus. For the sake of simplicity we refer to these¯ies as Df(250). In situ hybridization using Digoxigenin-labeled cDNA probes to detect the spatial distribution of twi (left) or sna (right) transcript in wild-type (OREGON R) embryos (A,B), dl/1 (C,D) twi/1 (E,F) embryos, dl/1; Df(250)2C). These results show, that the region between amino acids 402±531 of the Dorsal activation domain mediates the interaction with TAF II s.
The Twist activation region has been mapped to amino acids 1±330 (Shirokawa and Courey, 1997) . This activation region interacted with TAF II 110 (Fig. 2D ). In contrast, the truncated proteins T(1±141) and T(330±491), lacking the entire or a part of the activation-region, failed to interact with TAF II 110 (Fig. 2D ). These results demonstrate that Twist amino acids 141-330 mediate the interaction with TAF II 110. In summary, these results show that the activation domains of Dorsal and Twist interact with TAF II -subunits of the TFIID complex.
Dorsal-and Twist-dependent transcriptional activation is mediated by TFIID
The ®nding that Dorsal and Twist interact with TAF II s implies that Dorsal and Twist may utilize the basal transcription factor TFIID to activate transcription. As an initial step to provide supporting evidence for this hypothesis, we investigated the cofactor requirements for Dorsal-and Twist-dependent activation of transcription in cell-free transcription reactions. For these experiments we used recombinant Dorsal and Twist (Fig. 3A) and a reconstituted Drosophila transcription system, which contained partially puri®ed basal transcription factors, RNA polymerase II and was supplemented with either recombinant TBP or endogenous TFIID Sauer et al., 1995) . To monitor activation, we used a reporter gene comprised of ®ve DNA-binding sites for Dorsal and Twist, a core-promoter and the bacterial gene encoding chloramphenicol-acetyltransferase (cat). In the absence of activators, TBP and TFIID supported a low basal level of reporter gene transcription (Fig. 3C , lanes 1, 3, 5 and 7). In addition, reactions containing TBP failed to support activation by Dorsal or Twist (Fig. 3C , lanes 2 and 6). In contrast, TFIID mediated activation by Dorsal and Twist ( Truncations of Dorsal and Twist lacking the activationregion (Shirokawa and Courey, 1997) failed to activate transcription in the presence of TFIID (Fig. 3C , lanes 10 and 13). These results indicate that TAF II -subunits within the Dorsal and Twist synergistically activate transcription in different organisms (Shirokawa and Courey, 1997; Stein et al., 1998) . To investigate whether TAF II s mediate cumulative activation by Dorsal and Twist, we assayed transcription in the presence of TFIID and both activators. Compared to reactions containing either Dorsal or Twist, the level of reporter gene transcription was signi®cantly enhanced in the presence of both activators (Fig. 3C, lane 18) . These results indicate that TAF II s mediate cumulative transcriptional activation by Dorsal and Twist.
Dorsal and Twist dependent transcriptional activation involves TAF II s
To investigate the functional relevance of the identi®ed TAF II :activator interactions, we made use of the in vitro assembly of partial TBP-TAF II complexes (Chen et al., 1994) . Different complexes were assembled: double complexes containing the core-subunits TBP and TAF II 250 and triple complexes containing, in addition to TBP and TAF II 250, either TAF II 110 or TAF II 60 (Fig. 3B) .
TBP-TAF II 250 complexes failed to support activation by Dorsal or Twist (S. Mu Èller, F. Sauer, unpublished data). In contrast, TBP-TAF II 250-TAF II 110 complexes mediated transcriptional activation by Dorsal and Twist (Fig. 3D) . TBP-TAF II 250-TAF II 60 complexes supported transcriptional activation by Dorsal but not Twist (Fig. 3D) . These results show that TAF II 110 mediates transcriptional activation by Dorsal and Twist, while TAF II 60 mediates Dorsaldependent transcriptional activation only.
The ®nding that TAF II 110 supports transcriptional activation by Dorsal and Twist led us to investigate whether TAF II 110 could support transcriptional synergy by Dorsal and Twist. Compared to the level of transcriptional activation mediated by saturating concentrations of either activator alone (Fig. 3E, lanes 2 and 3) , reporter gene transcription was signi®cantly, more than additive, enhanced in the presence of TBP-TAF II 250-TAF II 110 complexes and both, Dorsal and Twist (Fig. 3E, lane 4) . In contrast, triple TBP-TAF II complexes containing TAF II 60 did not support transcriptional synergy (Fig. 3E, lane 8 (Sauer et al., 1996) . The dominantnegative TAF II -alleles, TAF60YY and TAF110D C, encode proteins, which fail to bind TAF II 250 and to become integrated into the TFIID complex in vivo. However, the mutant TAF II s are capable of squelching transcriptional activation by sequestering activators into transcriptional inactive complexes (Sauer et al., 1996; Zhuo et al., 1998) . As the initial step we used in vitro biochemistry to assess the effect of the mutant TAF II s on transcriptional activation by Dorsal and Twist. Protein:protein bindings assays indicate that TAF II 110DC interacted with Dorsal and Twist (Fig. 4A,  lanes 3 and 6) , while TAF II 60YY bound Dorsal only (Fig.  4A, lane 9) . Transactivation by Dorsal was alleviated in the presence of TAF II 110DC or TAF II 60YY (Fig. 4B) , while Twist-dependent transcriptional activation was inhibited in the presence of TAF II 110DC only (Fig. 4C) . These results indicate that the mutant TAF II s squelch transcriptional activation by Dorsal and Twist in vitro.
To investigate whether mutations in TAF II 110 and TAF II 60 affect Dorsal-and Twist-dependent activation of transcription in Drosophila embryos, we used in situ hybridization to monitor the transcription of the Dorsal and Twist target genes twi and sna in homozygous mutant TAF110D C or TAF60YY embryos. To enhance the possibility for detecting squelching effects, the embryos also contained a reduced activator gene-dosage.
Compared to dl/1 or twi/1 embryos (Fig. 1C±F ) twi and sna expression was signi®cantly reduced in dl/1; TAF110D C 2 (Fig. 5A,B ) and dl/1; TAF60YY 2 (Fig.  5C,D) embryos. twi and sna were expressed in only 14±16 and 12±14 ventral-most cells, respectively. In addition, 55% of the mutants exhibited gaps within the twi and sna expression domain, which were located in the region of the presumptive cephalic furrow. In contrast, twi and sna expression was apparently neither affected in dl/1; TAF110D C/1 (Fig. 5E,F) or dl/1; TAF60YY/1 (Fig.  5G,H) heterozygotes nor in TAF110D C 2 (Fig. 5I ,J) or TAF II 60YY 2 (Fig. 5K,L) homozygous mutant embryos. These results suggest that the activation of twi and sna expression requires a gene dosage sensitive interplay of Dorsal with TAF II 110 or TAF II 60.
Narrower twi and sna expression domains and gaps within the sna expression domain were also observed in twi/1; TAF110D C 2 embryos (Fig. 6A,B) . In contrast, twi and sna expression was unaffected in twi/1; TAF60YY 2 embryos (Fig. 6C,D) . Moreover, twi-sensitized, TAF110D C/1 embryos and homozygous mutant TAF110D C embryos exhibited a normal twi and sna transcription pattern (A.-D. Pham, F. Sauer, unpublished data). These results indicate that a gene dosage sensitive interaction of Twist and TAF II 110 is involved in the activation of mesoderm-determining gene expression.
It is important to note that apparently twi and sna expression is alleviated in lateral cells only, which due to the graded distribution of Dorsal and Twist contain the lowest activator concentrations within the twi and sna expression domain. The simplest explanation for this effect might be that mutant TAF II s compete with maternally contributed wild-type TAF II s allowing ef®cient squelching only in cells containing low activator concentrations.
Transcription of twi and sna in the central region of the Drosophila embryo involves TAF II 110
The ®nding that a mutation of TAF II 110 alleviates twi and sna transcription in dl-and twi-sensitized embryos led us to investigate the role of TAF II 110 for cumulative activation by Dorsal and Twist in vivo. We therefore monitored twi and sna transcription in homozygous TAF II -mutant embryos sensitized for both activators. The simultaneous reduction of the activator gene dosages resulted in narrowing of the twi and sna expression domain and the formation of a gap in the region of the presumptive cephalic furrow (Fig. 6E,F) . These alterations were enhanced in dl/1; twi/1; TAF60YY -embryos, in that the expression domains of both genes were even narrower and the gap widened (Fig.   6G,H) . However, even more dramatic alterations were observed in dl/1; twi/1; TAF110D C 2 embryos. In 20% of these mutants twi and sna transcription was alleviated in the central region of the embryo and sna expression was restricted to patches near the anterior and posterior pole (Fig. 6I,J) . These results suggest that a cumulative gene dosage sensitive interplay of Dorsal and Twist with TAF II 110 plays an important role for the activation of snail and twi expression in the central region of Drosophila embryos.
Discussion
The transcription factors Dorsal and Twist initiate meso- derm differentiation in Drosophila by activating the expression of key regulatory genes (Rush and Levine, 1996) . We have used a combination of in vitro protein-binding assays, cell-free transcription reactions and in vivo gene dosage assays to investigate the mechanism underlying transcriptional activation by Dorsal and Twist. Our studies provide evidence that a coordinate interplay of Dorsal and Twist with TAF II s is required for transcriptional activation of mesoderm-determining genes in the Drosophila embryo. Dorsal and Twist are members of the evolutionary highly conserved Rel and bHLH transcription factor families, respectively (Nolan and Baltimore, 1992; Jan and Jan, 1993; Verma et al., 1995) . Rel transcription factors (i.e. NF-k B, c-Rel) and bHLH transcription factors (i.e. MyoD, NeuroD) have been implicated to control transcription during divergent biological events (Jan and Jan, 1993; Weintraub, 1993; Baeuerle and Baltimore, 1996; Lee, 1997) . Recent studies suggest that NF-kB initiates vertebrate limb formation by activating twi expression (Bushdid et al., 1998; Kanegae et al., 1998) . Our results provide a molecular mechanism for transactivation by Rel and bHLH factors, which may serve as basis to investigate the mechanism underlying transcriptional activation by Rel and bHLH transcription factors in vertebrates.
Transcriptional activation by Dorsal and Twist
As the initial step to dissect transcriptional activation by (Fig. 2) . These ®ndings support the hypothesis that TAF II 110 may represent the predominant target for glutamine-rich activation domains (Hoey et al., 1993; Chen et al., 1994; Sauer et al., 1995) . TAF II 60 has been shown to interact with alanine-or isoleucine-rich activation domains (Chen et al., 1994; Sauer et al., 1995 -embryos (C,D) (cross: twi/1;TAF60YY/1 females and TAF60YY/1 males). (E± J) twi and sna expression in dl, twi double heterozygotes. Expression was monitored in dl/1; twi/1 (E,F) (cross: dl/1 females and twi/1 males) or dl/1; twi/1; TAF60YYvators for Dorsal-and Twist-dependent transcriptional activation. Simultaneous interactions between different activators and distinct TAF II -subunits mediate synergistic activation of transcription in vitro (Sauer et al., 1995) . Our result, that partial TBP-TAF II complexes containing TAF II 110 mediate transcriptional synergy by Dorsal and Twist (see Fig. 3 ) presents evidence that simultaneous interactions of different activators and a common target within the TFIID complex may support synergistic activation of transcription. One possible explanation for this phenomenon might be that Dorsal and Twist bind TAF II 110 simultaneously by contacting different regions within the coactivator. However, we favor the possibility that multiple copies of TAF II 110 may be present in the partial TBP-TAF II complexes. Thus, different activators would bind simultaneously to the same TFIID complex by contacting different TAF II 110 subunits.
Our results imply that TAF II s mediate simple as well as synergistic activation by Dorsal and Twist in vitro. However, we can not exclude the possibility that factors other than TAF II s may contribute to transcriptional activation by Dorsal and Twist. For example, Dorsal interacts with human TBP (Kerr et al., 1993) . Although our results indicate that TBP is unable to mediate transcriptional activation by Dorsal and Twist in vitro (Fig. 3) , it remains possible that the observed transactivation by Dorsal may depend on multivalent interactions of Dorsal with TAF II s and TBP.
Activation of twi and sna transcription
To investigate the functional relevance of the in vitro de®ned TAF II -coactivators for Dorsal-and Twist-dependent transcriptional activation in Drosophila, we monitored the expression of the mesoderm-determining genes twi and sna in TAF II -mutant embryos containing a reduced activatordosage. Our in vivo analyses demonstrate that gene dosage sensitive interactions between TAF II 110 or TAF II 60 with dorsal and TAF II 110 with twi are required for the activation of twi and sna expression. These results strongly imply that mutations in TAF II -subunits of the TFIID complex inhibit transcriptional activation by Dorsal or Twist.
Combined with our in vitro biochemistry the gene dosage assays strongly imply that interactions of Dorsal with TAF II 110 or TAF II 60 and Twist with TAF II 110 mediate activation of twi and sna expression in the embryo. However, we can not exclude the possibility that the alleviation of twi and sna expression re¯ects a rather general than activator-speci®c effect of the TAF II -mutations. We favor the view that the observed reduction of twi and sna expression is a result of disrupted interactions between Dorsal and Twist with TAF II s. First, several TAF II s directly contact DNA ( Hoffmann et al., 1996; Verrijzer and Tjian, 1996; Burley et al., 1997) . However, neither TAF II 110 (Hoey et al., 1993) , TAF II 60 nor their corresponding human homologues TAF II 135 (Tanese et al., 1996) , TAF II 105 (Dikstein et al., 1996) and TAF II 70 , apparently do. Thus, it is therefore most likely that the requirement of TAF II s for twi and sna transcription may re¯ect speci®c interactions of TAF II s with activators rather than with DNA. This hypothesis is supported by the result, that the mutants TAF II 60YY and TAF II 110DC interact with Dorsal and Twist and inhibit transcriptional activation by these activators in vitro. Thus, in the embryo the mutant TAF II s may sequester Dorsal and Twist into transcriptional inactive complexes and thereby inhibit the interaction of the activators with TAF II 110 or TAF II 60 present in the endogenous TFIID complexes. Moreover, the result that a mutation in TAF II 60 inhibits Dorsal-but not Twist-dependent activation of twi and sna expression implies, that the observed alleviation of mesoderm-determining transcription may, at least in the case of TAF II 60, re¯ect a disruption of functional activator: TAF IIinteractions rather than a general alleviation of transcription.
Recently, Bicoid-dependent transcriptional activation in the Drosophila embryo was found to involve TAF II 110 or TAF II 60 (Sauer et al., 1996) . In this context, it is important to note that the reduced transcription of one Bicoid target gene, hunchback, in TAF II -mutant embryos has been incorrectly attributed to mutations in TAF II s (Sauer et al., 1998) . Our results provide evidence that TAF II 110 or TAF II 60 play an essential role for the activation of twi and sna expression by Dorsal and Twist in the Drosophila embryo.
The alleviation of twi and sna expression in the absence of functional TAF II 110 and TAF II 60 raises the possibility, that interactions with these co-activators are suf®cient for Dorsal and Twist to activate the transcription of mesodermdetermining genes. Recently, Dorsal-dependent activation of twi transcription was found to require dCBP, a histoneacetyl transferase, suggesting that twi expression may also be regulated at the level of chromatin remodeling (Akimura et al., 1997) . Thus, twi transcription may be activated by a proposed`triangle mechanism' (Struhl, 1996) involving the simultaneous or successive interactions of Dorsal with dCBP and TAF II s.
TAF II 110 plays an essential role for the initiation of mesoderm formation
A similar study concerning the role of TAF II s for Dorsaldependent activation of twi and sna expression has been reported recently (Zhuo et al., 1998) . A combination of in vitro biochemistry and gene dosage assays provides evidence that Dorsal interacts with TAF II 110 and TAF II 60 and that mutations in either of these TAF II -subunit alleviate transcriptional activation by Dorsal in the Drosophila embryo. These recent studies imply that TAF II s mediate Dorsal-dependent activation of transcription in Drosophila. Our results extend these studies by showing that the expression of mesoderm-determining genes in Drosophila is activated by a cumulative interplay of Dorsal and the bHLH transcription factor Twist with TAF II -subunits of the TFIID complex. These results provide a molecular basis for how Dorsal cooperates with bHLH transcription factors in order to activate gene expression in Drosophila.
Dorsal cooperates with bHLH factors to activate transcription in the embryo (Rush and Levine, 1996) . For example, Dorsal cooperates with several distinct bHLH factors (i.e. Daughterless, T4) in order to activate the expression of the neuroectoderm-determining gene rhomboid (rho) (Ip et al., 1992a; Gonza Âles-Crespo and Levine, 1993; . The close linkage of Dorsal and bHLH factor DNA target sites in the rho enhancer and the direct interaction of T4 with Dorsal led to the proposal that cooperative binding to DNA may represent the underlying mechanism for how Dorsal and bHLH factors activate rho expression (Gonza Âles-Crespo and Levine, 1993; .
Our gene dosage assays provide several lines of evidence that a cumulative interplay of Dorsal and Twist with TAF II 110 activates the expression of the mesoderm-determinants twi and sna. First, the alleviation of twi or sna expression in dorsal-or twi-sensitized, homozygous mutant TAF II embryos suggests that the inhibition of transcriptional activation by either Dorsal or Twist is suf®cient to prevent the expression of mesoderm-determining genes. These results imply that Dorsal and Twist act in a cumulative rather than additive or redundant fashion (Figs. 5 and 6 ). This hypothesis is supported by the observation, that sna expression is almost completely extinguished in the central region of homozygous mutant TAF110D C embryos, which contain a reduced Dorsal and Twist concentration (Fig. 6J) . These ®ndings imply that a cumulative interplay of Dorsal and Twist with TAF II 110 activates the expression of twi and sna at least in the central region of Drosophila embryos.
In contrast to rho, the sna enhancer contains unlinked Dorsal and Twist DNA target sites (Ip et al., 1992b) suggesting that cooperative binding to DNA or interactions between Dorsal and Twist may not contribute to the activation of sna expression by Dorsal and Twist. Thus, our results provide evidence that Dorsal and Twist, when bound to unlinked DNA target sites within the sna enhancer, activate transcription by a cumulative interplay with TAF II 110.
The twi enhancer/promoter region differs from the sna enhancer in that it does not contain DNA target sites for Twist (Jiang et al., 1991; Pan et al., 1991; Thisse et al., 1991) . It is thought, that Dorsal recruits Twist to the twi promoter by direct protein:protein interactions ( Gonza Âles-Crespo and Shirokawa and Courey, 1997) . Thus, our results imply that despite the different interaction of the activators at the twi and sna enhancer, Dorsal and Twist may utilize the same TAF II -dependent mechanism to activate the expression of the mesoderm-determining genes.
Genetic studies have led to the proposal that Dorsal alone is suf®cient to activate twi and sna expression in cells containing peak Dorsal concentrations. It is thought that the synergistic interplay between Dorsal and Twist is required to activate twi and sna expression only in those cells containing low Dorsal concentrations (Ip et al., 1992b; Gonza Âles-Crespo and Levine, 1993; . In contrast, our results that twi and sna expression is extinguished in the central region of dl/1; twi/1; TAF110D C 2 embryos (Fig. 6I,J) , imply that in addition to Dorsal, transcriptional activation by Twist is required to activate the expression of mesoderm-determining genes even in those cells containing peak Dorsal-concentrations. Genetic studies provide evidence that Dorsal cooperates with several bHLH factors other than Twist in order to activate twi and sna expression Gonza Âles-Crespo and Levine, 1993) . Given that these interactions function in a redundant fashion, the alleviation of sna expression in embryos lacking TAF II 110 (Fig. 6J) , implies that not only the cumulative interplay of Dorsal with Twist but also between Dorsal and other bHLH transcription factors may be abolished in the absence of functional TAF II 110. However, in the absence of TAF II 110, sna expression is alleviated in the central region of the embryos but not near the anterior and posterior poles (Fig. 6J) . This raises the possibility that in anterior and posterior regions of the embryo sna expression may be activated by regionspeci®c interactions of Dorsal and Twist with coactivators other than TAF II s. Alternatively, transcription factors other than Dorsal and twist may activate sna expression in the pole regions of embryos. This thesis is supported by stringent analyses of the sna-enhancer region (Ip et al., 1992b) .
Materials and methods

Plasmids
Plasmids for in vitro transcription/translation were based on pTbSTOP (Sauer et al., 1995) . Plasmid expressing Twist, T(1±141), T(1±330), T(330±490), Dorsal, D(1± 402), D(1±531) or D(402±678) were generated by inserting corresponding dl and twi cDNA fragments into pTb STOP. Plasmids expressing TAF II 250, TAF II 110, TAF II 110DC, TAF II 60, TAF II 60YY, TAF II 30b or TFIIB have been described (Sauer et al., 1995; Sauer et al., 1996) . Baculovirus plasmids for the expression of Flag-epitope tagged Dorsal, Twist, D(1±402) or T(330±490) were created by inserting the corresponding dl or twi cDNAs into pSLFlag (Lichtsteiner and Tjian, 1995) . Expression plasmids for TAF II 110, TAF II 110DC, TAF II 60 and TAF II 60YY have been described (Sauer et al., 1995) . To generate the reporter plasmid phb55CAT (5 £ TD) oligonucleotides containing a Twist and Dorsal DNA-binding site (Shirokawa and Courey, 1997) were annealed and ligated in the presence of BglII and BamHI to generate head-to-tail multimers. The species corresponding to ®ve copies of the oligomer was inserted into pBlueBglII (Sauer et al., 1996) to generate pBlue(5 £ TD). A 2.2 kb HindIII fragment from phb55CAT (Driever and Nu Èsslein-Volhard, 1989 ) containing the hunchback core-promoter and the chloramphenicol-acetyltransferase (CAT) gene, was inserted into the HindIII site of pBlue(5£ TD) to generate phb55CAT(5 £ TD).
Puri®cation of Flag-epitope tagged proteins from SF9 cells
Recombinant baculovirus expressing Flag-epitope tagged proteins and the puri®cation of Flag epitope tagged proteins from cell extracts were performed as described (Sauer et al., 1995) .
Fly strains
Flies were propagated under standard conditions at 258C. The following alleles were used: dl I (Roth et al., 1989) ; twi ID96 (Jiang et al., 1991) ; TAF110D C and TAF60YY (Sauer et al., 1996) and Df(3R) . Stocks were obtained from the Bloomington Stock Center and from D.A. Wassarman. Details of these strains can be found in Sauer et al. (1996) and Lindsley and Zimm (1992) .
Embryo analysis
Immunohistochemical whole mount in situ hybridization was performed as described (Tautz and Pfei¯e, 1989; Sauer et al., 1996) . Embryos used for immunohistochemical staining were collected at 258C. Approximately 3000 embryos collected from three individual crosses were scored for each of the shown genotypes. 55% of dl-or twi-sensitized TAFD C110 2 or TAF60YY 2 embryos exhibited altered twi and sna patterns as shown in Figs. 5 and 6. Although somewhat more variable, approximately 25% of the embryos sensitized for Dorsal and Twist lacking TAF II 60 or TAF II 110 exhibited the patterns shown in Fig. 6 . Mutant embryos were identi®ed by the absence of lacZ staining mediated by P(ftzlacZ) or P(hblacZ) reporter genes present on balancers for the second and third chromosome.
Protein interaction assays
Protein binding assays were performed as described Sauer et al., 1995) . Brie¯y, 35 S-methionine labeled proteins were generated using thè TNT coupled in vitro transcription/translation system' (Promega). Anti-Flag antibody resin loaded with ,100 ng bait protein was incubated with in vitro expressed 35 Smethionine labeled target proteins. Protein complexes were separated by SDS-PAGE and radiolabeled proteins were detected by autoradiography (Sauer et al., 1995) .
4.6. In vitro assembly of partial TBP-TAF II complexes dTBP, Hemaglutinin (HA)-epitope tagged TAF II 250 and Flag-epitope tagged TAF II 110 and TAF II 60 were expressed as described (Chen et al., 1994; Sauer et al., 1995) . TBP-TAF II complexes were assembled as described (Chen et al., 1994; Sauer et al., 1995) .
In vitro transcription
Basal transcription factors and RNA polymerase II were puri®ed from nuclear extracts prepared from 0-to 12-h-old Drosophila embryos essentially as described Austin and Biggin, 1996) . In vitro transcription reactions contained 20 ng recombinant TBP, approximately 200 ng TFIID, 25 ng TFIIA (both subunits), 40 ng recombinant TFIIB, 2 ml TFIIE (superose 6 fraction), 0.5 ml TFIIF (Superdex-200 fraction), 1 ml TFIIH (Mono-S fraction) and 2 ml RNA polymerase II (P11 fraction). Transcription products were analyzed by primer extension and the reaction product (191 nt) was visualized by autoradiography (Sauer et al., 1995) .
